Market News
Latest news from Stock markets.
UPS and FedEx Ground MD-11 Fleets After Deadly Kentucky Plane Crash
UPS said it took the step “out of an abundance of caution” and on the recommendation of the jet's manufacturer.
...keep reeding on wsj.com
USA Rare Earth: Back To Earth
USA Rare Earth offers a bullish opportunity as it ramps up U.S. magnet production and expands via the LCM acquisition in the U.K. USAR aims for full vertical integration in rare earths, addressing U.S. supply chain vulnerabilities and national priorities amid ongoing China trade tensions. The company is pre-revenue, with major production and financial milestones expected from 2026 onward; current cash reserves and warrant redemptions support expansion.
...keep reeding on seekingalpha.com
KKR & Co.: Consistent Performance Despite Credit Fears (Rating Upgrade)
KKR & Co. shares have underperformed, but strong Q3 results and robust fundraising highlight resilient fundamentals despite private credit concerns. KKR's $126 billion in dry powder and sticky AUM base provide revenue visibility and insulation from potential fundraising slowdowns. Fee-related earnings and management fees remain the core, less cyclical driver of the company's cash flow, with segment growth across private equity, real assets, and credit.
...keep reeding on seekingalpha.com
USA Rare Earth, Inc. (USAR) Q3 2025 Earnings Call Transcript
USA Rare Earth, Inc. ( USAR ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Lionel McBee - Vice President of Investor Relations Barbara Humpton - CEO & Director William Steele - Chief Financial Officer Conference Call Participants Neal Dingmann - William Blair & Company L.L.C., Research Division George Gianarikas - Canaccord Genuity Corp., Research Division Derek Soderberg - Cantor Fitzgerald & Co., Research Division Subhasish Chandra - The Benchmark Company, LLC, Research Division Sujeeva De Silva - ROTH Capital Partners, LLC, Research Division Presentation Operator Good afternoon, and welcome to USA Rare Earth's 2025 Third Quarter Earnings Conference Call.
...keep reeding on seekingalpha.com
THQ: A CEF That Distributes 'Uncertainty' Across The Healthcare Segment
abrdn Healthcare Opportunities Fund is an actively managed, income-oriented CEF that stands out for its competitive distribution. The yield above 12% comes from a combination of factors, including financial leverage. It is exposed to the traditional healthcare segment, with forward P/Es close to the 30-year average and an undervalued potential re-rating.
...keep reeding on seekingalpha.com
PCM: Limited Value Here Going Into 2026
PCM Fund is evaluated as an investment, focusing on its strategy of high current income via non-agency mortgage and high-yield corporate debt. Despite a generally risk-on market, PCM has delivered only modest returns, validating a cautious stance. I view the premium to NAV, weak income metrics, and outpacing of downgrades (over upgrades) in the high yield credit market as all reasons to stay on the sidelines.
...keep reeding on seekingalpha.com
1 Stock-Split Stock to Buy Now -- It Has More Upside Than Palantir Technologies, According to Wall Street
Presently, the median target price on Palantir Technologies implies 17% upside, but the median target price on O'Reilly Automotive implies 20% upside. Palantir is a leader in artificial intelligence (AI) and machine learning platforms, but the stock trades at an unsustainable valuation.
...keep reeding on fool.com
Why Super Micro Computer Still Holds Promise For Aggressive Growth Investors
Super Micro Computer is poised for substantial growth driven by its innovative hardware solutions and increasing demand in the data center sector. One of its biggest risks is its low gross margins. The company recently reported declining gross margins in its first quarter FY 2026 report, sparking a selloff.
...keep reeding on seekingalpha.com
Global Net Lease: What The Results Actually Look Like
Global Net Lease reported a strong quarter, highlighting an investment-grade rating, debt reduction, and improved AFFO guidance. High occupancy and investment-grade tenants do not eliminate the risk of costly vacancies or property sales at low prices upon lease expirations. In fact, we have seen huge impairments and sales at low values, which have pushed the FFO lower over time.
...keep reeding on seekingalpha.com
Nvidia's AI Dominance: Data Center Revenue Poised for 165% Surge by 2027
Nvidia CEO Jensen Huang suggested the company has a big enough backlog to sustain the outstanding growth of the data center business. The prospects of Nvidia's data center business are aided by the huge amount of money that's going to be spent on AI infrastructure over the next couple of years.
...keep reeding on fool.com
VICI Properties Drives Shareholder Value With A New Transaction
VICI Properties remains a strong buy after delivering solid quarterly results and announcing a strategic, accretive sale-leaseback deal with GDEN. The $1.16B GDEN transaction enhances VICI's diversification, offers a 7.5% cap rate, and features a long-term, highly favorable triple net lease structure. VICI posted 5.3% AFFO per share growth in Q3 2025 and raised guidance, demonstrating resilience even in a high-interest rate environment.
...keep reeding on seekingalpha.com
eHealth: Undervalued And Gaining Momentum After Q3 Earnings Beat
eHealth Inc. is positioned for a turnaround, leveraging digital platform enhancements, cost optimization, and strong insurer partnerships. EHTH trades at a deep discount to peers despite improved financials, nearly debt-free balance sheet, and superior liquidity and margins. Key risks include seasonality, regulatory changes, and competition, but Q3 earnings and open enrollment are positive signs of a turnaround.
...keep reeding on seekingalpha.com
Exchange Income Corporation (EIF:CA) Q3 2025 Earnings Call Transcript
Exchange Income Corporation ( EIF:CA ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Michael Pyle - CEO & Director Richard Wowryk - Chief Financial Officer Jake Trainor - President Travis Muhr - Chief Administrative Officer Conference Call Participants Steven Hansen - Raymond James Ltd., Research Division Cameron Doerksen - National Bank Financial, Inc., Research Division James McGarragle - RBC Capital Markets, Research Division Matthew Lee - Canaccord Genuity Corp., Research Division Krista Friesen - CIBC Capital Markets, Research Division Tim James - TD Cowen, Research Division Jeff Fenwick - Cormark Securities Inc., Research Division Konark Gupta - Scotiabank Global Banking and Markets, Research Division Amr Ezzat - Ventum Financial Corp., Research Division Chris Murray - ATB Capital Markets Inc., Research Division Gary Ho - Desjardins Securities Inc., Research Division Razi Hasan - Paradigm Capital Inc., Research Division Michael Goldie - BMO Capital Markets Equity Research Presentation Operator Good morning, everyone.
...keep reeding on seekingalpha.com
VICI Properties: The Overlooked Expansion That Reinforces The Bull Case
VICI Properties is upgraded to a strong buy due to its solid core business and expanding diversification beyond gaming. VICI is strategically investing in experiential real estate, including college sports infrastructure and entertainment venues, broadening its growth opportunities. VICI's triple net model, disciplined capital allocation, and low expenses drive robust AFFO growth and support a 6% forward dividend yield.
...keep reeding on seekingalpha.com
Is Clarivate Stock a Buy After a Member of the Board of Directors Bought Shares for $2.5 Million?
Kenneth L. Cornick, a member of the Board of Directors for Clarivate, purchased 725,000 shares in the company. The purchase came a few days after Clarivate reported third quarter results on Oct. 29.
...keep reeding on fool.com
United Parcel Service: Buyer Beware, The Dividend Might Be Gone Next Year
Given the risk of a dividend cut and weak fundamentals, UPS's current valuation is unattractive; investors should proceed with caution. UPS's capital allocation is strained, with dividends and buybacks exceeding free cash flow, risking long-term balance sheet health. Revenue and volume declines limit UPS's ability to drive future cash flow growth despite aggressive cost-cutting.
...keep reeding on seekingalpha.com
Suzano S.A. (SUZ) Q3 2025 Earnings Call Transcript
Suzano S.A. ( SUZ ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants João Fernandez de Abreu - CEO & Member of Management board Fabio Almeida Oliveira - Executive Vice President of Paper & Packaging Leonardo Grimaldi - Executive VP of Pulp Commercial & Logistics and Member of Management Board Aires Galhardo - Executive VP of Pulp, Operations Engineering & Energy and Member of Management Board Marcos Assumpcao - Chief Financial & Investor Relations Officer and Member of Management Board Luis Renato Bueno - Executive Vice President of Consumer Goods & Corporate Relations Conference Call Participants Caio Ribeiro - BofA Securities, Research Division Daniel Sasson - Itaú Corretora de Valores S.A.
...keep reeding on seekingalpha.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of V.F. Corporation
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In VFC To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in VFC between October 27, 2022 and May 20, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against V.F.
...keep reeding on prnewswire.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) and reminds investors of the November 17, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of WPP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In WPP To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in WPP between February 27, 2025 and July 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against WPP plc ("WPP" or the "Company") (NYSE: WPP) and reminds investors of the December 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of James Hardie
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In James Hardie To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in James Hardie between May 20, 2025 and August 18, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against James Hardie Industries plc ("James Hardie" or the "Company") (NYSE: JHX) and reminds investors of the December 23, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
BDC Weekly Review: Initial Q3 Reports And NII Catalysts
We take a look at the action in business development companies through the last week of October and highlight some of the key themes we are watching. BDCs were flat on the week, outperforming all other credit sectors. We highlight key NII drivers, which include credit spreads, leverage, interest expense, portfolio allocation, and non-accruals, with spreads currently pressuring NII lower.
...keep reeding on seekingalpha.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Baxter between February 23, 2022 and July 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. ("Baxter" or the "Company") (NYSE: BAX) and reminds investors of the December 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Jasper between November 30, 2023 and July 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ: JSPR) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Quanex Building Products
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Quanex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Quanex between December 12, 2024 and September 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Quanex Building Products Corporation ("Quanex" or the "Company") (NYSE: NX) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
Diageo considers external candidates for CEO role, including outgoing GSK boss, FT reports
Diageo , the world's top spirits maker, has considered external candidates to be its chief executive, including outgoing GSK CEO Emma Walmsley, the Financial Times reported on Saturday, citing people familiar with the situation.
...keep reeding on reuters.com
Lojas Renner S.A. (LRENY) Q3 2025 Earnings Call Transcript
Lojas Renner S.A. (OTCPK:LRENY) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Fabiana Oliver Fabio Faccio - Chief Executive Officer Daniel dos Santos - Vice President of Finance, Administrative & Investor Relations Conference Call Participants Luiz Guanais - Banco BTG Pactual S.A.
...keep reeding on seekingalpha.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of KBR
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in KBR between May 6, 2025 and June 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against KBR, Inc. ("KBR" or the "Company") (NYSE: KBR) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in aTyr between January 16, 2025 and September 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR) and reminds investors of the December 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
LRN INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Stride
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Stride To Contact Him Directly To Discuss Their Options If you suffered significant losses in Stride stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Stride, Inc. ("Stride" or the "Company") (NYSE: LRN).
...keep reeding on prnewswire.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH) and reminds investors of the December 2, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
American Superconductor: Back To Earth After Runaway Momentum
American Superconductor Corp. shares plunged 40% after Q3 results failed to exceed elevated AI-driven expectations. AMSC's growth profile has been volatile, with recent profitability but a mixed long-term track record and significant share dilution. Current valuation stands at 5x sales, with minimal sequential growth and modest margins, raising caution despite a strong cash position.
...keep reeding on seekingalpha.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marex Group
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Marex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Marex between May 16, 2024 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Marex Group plc ("Marex" or the "Company") (NASDAQ: MRX) and reminds investors of the December 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Synopsys
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Synopsys To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Synopsys between December 4, 2024 and September 9, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ: SNPS) and reminds investors of the December 30, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CarMax
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In CarMax To Contact Him Directly To Discuss Their Options If you suffered losses in CarMax between June 20, 2025 and September 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against CarMax, Inc. ("CarMax" or the "Company") (NYSE: KMX) and reminds investors of the January 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lantheus To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Lantheus between February 26, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) and reminds investors of the November 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
Thomson Reuters: Staying Neutral As Near-Term Organic Growth May Slow Further
Maintain a Hold rating on Thomson Reuters due to valuation concerns and emerging headwinds in key business segments. TRI demonstrates solid operational execution, with 7% organic growth and strong AI-driven momentum in the Legal Professionals segment. New challenges include sales disruption in Corporates and ongoing government contract reductions in Legal Professionals, impacting near-term growth.
...keep reeding on seekingalpha.com
VFC DEADLINE: ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages V.F. Corporation Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action - VFC
New York, New York--(Newsfile Corp. - November 8, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of V.F. Corporation (NYSE: VFC) between October 30, 2023 and May 20, 2025, both dates inclusive (the "Class Period"), of the important November 12, 2025 lead plaintiff deadline.
...keep reeding on newsfilecorp.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In MoonLake To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in MoonLake between March 10, 2024 and September 29, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Reuters Research Inc. ("MoonLake" or the "Company") (NASDAQ: MLTX) and reminds investors of the December 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Avantor To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Avantor between March 5, 2024 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 8, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. ("Avantor" or the "Company") (NYSE: AVTR) and reminds investors of the December 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
...keep reeding on prnewswire.com
Spire Global: A Buy Even For Late Comers
Spire Global is rated a Buy, with a reset business model focused on satellite data and space services after divesting its Maritime segment. SPIR eliminated all debt following the $241M Maritime sale, improving liquidity and removing bankruptcy risk, despite recent operational and reporting setbacks. Management guides for $85M–$95M revenue in 2025 and 20% growth in 2026, with a focus on achieving positive free cash flow and leveraging new contracts.
...keep reeding on seekingalpha.com
Evergy Could Make Sense To Buy On Any Dips In The Price
Evergy, Inc. is a regulated utility serving Kansas and Missouri, offering a competitive 3.68% dividend yield and stable growth prospects. EVRG has outperformed utility peers and bonds, benefiting from population growth, data center expansion, and lower financing costs due to Fed rate cuts. Despite strong recent stock performance, EVRG's valuation is reasonable versus peers, and its dividend growth offers inflation protection for income investors.
...keep reeding on seekingalpha.com
Clean Harbors: Operational Discipline Is Paying Off, But The Price Already Knows It
Clean Harbors remains a well-run industrial services leader with strong cash flow and pricing power, despite a lackluster Q3 2025. Q3 results showed flat revenue, improved margins, and robust free cash flow, but missed revenue estimates and lowered full-year EBITDA guidance. Kimball facility ramp-up and Safety-Kleen Sustainability Solutions' base oil spread recovery are key to future upside, but near-term headwinds persist.
...keep reeding on seekingalpha.com
WELL Health Technologies Corp. (WELL:CA) Q3 2025 Earnings Call Transcript
WELL Health Technologies Corp. ( WELL:CA ) Q3 2025 Earnings Call November 6, 2025 1:00 PM EST Company Participants Tyler Baba - Manager of Investor Relations Hamed Shahbazi - Founder, Chairman & CEO Eva Fong - Chief Financial Officer Conference Call Participants David Kwan - TD Cowen, Research Division Derek Greenberg Rob Goff - Ventum Financial Corp., Research Division Erin Kyle - CIBC Capital Markets, Research Division Michael Freeman - Raymond James Ltd., Research Division Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the WELL Health Technologies Corp. Third Quarter 2025 Earnings Release Conference Call.
...keep reeding on seekingalpha.com
Steve Madden Is Back To Pre-Tariff Valuation Despite A Worse And Uncertain Outlook
Steve Madden reported weak 3Q25 results, with core wholesale revenues and margins significantly impacted, excluding Kurt Geiger acquisitions. SHOO is highly exposed to China tariffs, which continue to pressure margins and operating profitability, with no repeal yet in place. Temporary revenue losses are expected to normalize, but ongoing tariff uncertainty keeps future margin recovery in question.
...keep reeding on seekingalpha.com
Concentra Group Holdings Parent, Inc. (CON) Q3 2025 Earnings Call Transcript
Concentra Group Holdings Parent, Inc. ( CON ) Q3 2025 Earnings Call November 7, 2025 9:00 AM EST Company Participants William Newton - CEO & Director Matthew DiCanio - President & CFO Conference Call Participants Ann Hynes - Mizuho Securities USA LLC, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Justin Bowers - Deutsche Bank AG, Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division Michael Murray - RBC Capital Markets, Research Division Presentation Operator Good morning, and thank you for joining us today for Concentra Group Holdings Parent, Inc. Earnings conference call to discuss the third quarter 2025 results. Speaking today are the company's Chief Executive Officer, Keith Newton; and the company's President and Chief Financial Officer, Matt DiCanio.
...keep reeding on seekingalpha.com
IGM Financial Inc. (IGM:CA) Q3 2025 Earnings Call Transcript
IGM Financial Inc. ( IGM:CA ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Kyle Martens James O'Sullivan - President, CEO & Director Damon Murchison - President & CEO of IG Wealth Management Luke Gould - President & CEO of Mackenzie Investments Keith Potter - Executive VP & CFO Conference Call Participants Jaeme Gloyn - National Bank Financial, Inc., Research Division Graham Ryding - TD Cowen, Research Division Presentation Operator Thank you for standing by. This is the conference operator.
...keep reeding on seekingalpha.com
Nathan's Famous: Profits Cooling, Payouts Heating Up
Nathan's Famous remains a solid asset-light compounder, delivering strong returns and announcing a special $2.50 dividend for December. NATH's Branded Products Program drove revenue growth but suffered an operating loss due to rising beef prices, compressing EBITDA margins. Despite margin pressure, dividends are well covered by free cash flow, resulting in an attractive 4.2% shareholder yield for FY 2026.
...keep reeding on seekingalpha.com
Amgen: Buy This Cheap Biotech Leader
Amgen is a biotech leader with strong sales growth, key products outperforming, and an impressive R&D pipeline fueling future prospects. Despite political headwinds and margin pressures, AMGN raised full-year guidance and is implying resilient bottom-line growth. The stock trades at a significant valuation discount to sector peers, making AMGN an attractive value play in the current environment.
...keep reeding on seekingalpha.com